Verus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Buy
344
+1
+0.3% +$1.01K 0.29% 43
2025
Q4
$369K Buy
343
+11
+3% +$10.5K 0.34% 42
2025
Q3
$253K Sell
332
-20
-6% -$14.9K 0.24% 53
2025
Q2
$274K Buy
352
+5
+1% +$3.88K 0.28% 49
2025
Q1
$287K Hold
347
0.31% 43
2024
Q4
$268K Buy
+347
New +$287K 0.3% 45

Other funds holding LLY

Verus Wealth Management's LLY Position: Q1 2026 in Review

Verus Wealth Management increased its Eli Lilly (LLY) stake by 0.29% in Q1 2026, buying an estimated $1.01K and bringing the position to 344 shares worth $316K. The position accounts for 0.29% of the portfolio, ranked #43.

Verus Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $369K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Verus Wealth Management held 344 shares of Eli Lilly worth $316K as of Q1 2026.
  • Verus Wealth Management bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.29% of Verus Wealth Management's portfolio in Q1 2026, its #43 holding.
  • Verus Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Verus Wealth Management's Eli Lilly position peaked at $369K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Verus Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.